
Linde (LIN) reported Q2 2025 adjusted EPS of $4.09, surpassing the $4.03 consensus, and revenues of $8.5 billion, beating estimates by 1.70%. While the company has consistently exceeded EPS forecasts over the last four quarters, it has topped revenue estimates only once. Despite a 9.9% year-to-date stock gain, Linde carries a Zacks Rank #4 (Sell) due to pre-earnings unfavorable estimate revisions and its industry's bottom-tier ranking, suggesting potential near-term underperformance.
Linde (LIN) delivered a solid Q2 2025 performance, reporting adjusted earnings of $4.09 per share and revenues of $8.5 billion, which surpassed consensus estimates by 1.49% and 1.70% respectively. This marks the fourth consecutive quarter of EPS beats and reflects year-over-year growth from $3.85 EPS and $8.27 billion in revenue. Despite this positive operational result and a 9.9% year-to-date stock gain that outpaces the S&P 500, significant headwinds are present. The company carries a Zacks Rank #4 (Sell), a rating predicated on an unfavorable trend in earnings estimate revisions leading up to the report. Furthermore, the company's revenue beat history is inconsistent, with this being the only upside surprise in the last four quarters. Compounding the cautious outlook, Linde operates within the Chemical - Specialty industry, which ranks in the bottom 30% of Zacks-ranked industries, a factor historically correlated with market underperformance. The key determinant for near-term price action will be management's forward-looking commentary and any subsequent revisions to analyst estimates.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.40
Ticker Sentiment